CN110812273A - Skin barrier moisturizing and repairing cream and preparation method thereof - Google Patents

Skin barrier moisturizing and repairing cream and preparation method thereof Download PDF

Info

Publication number
CN110812273A
CN110812273A CN201911265886.1A CN201911265886A CN110812273A CN 110812273 A CN110812273 A CN 110812273A CN 201911265886 A CN201911265886 A CN 201911265886A CN 110812273 A CN110812273 A CN 110812273A
Authority
CN
China
Prior art keywords
skin barrier
moisturizing
repairing
repairing cream
following components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201911265886.1A
Other languages
Chinese (zh)
Other versions
CN110812273B (en
Inventor
姚智荣
王北明
潘红炬
廖志刚
梁勇坤
严高剑
张超
龚俊瑞
柴将红
余良钟
肖娜
陈冬梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foshan Shunde Hengxingrun Medical Technology Co Ltd
Guangdong China Resources Shunfeng Pharmaceutical Co Ltd
Original Assignee
Foshan Shunde Hengxingrun Medical Technology Co Ltd
Guangdong China Resources Shunfeng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foshan Shunde Hengxingrun Medical Technology Co Ltd, Guangdong China Resources Shunfeng Pharmaceutical Co Ltd filed Critical Foshan Shunde Hengxingrun Medical Technology Co Ltd
Priority to CN201911265886.1A priority Critical patent/CN110812273B/en
Publication of CN110812273A publication Critical patent/CN110812273A/en
Application granted granted Critical
Publication of CN110812273B publication Critical patent/CN110812273B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295Liquid crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a skin barrier moisturizing and repairing cream and a preparation method thereof. The skin barrier moisturizing and repairing cream comprises the following components in percentage by weight: 9 to 25 percent of oily matrix, 1 to 10 percent of lipoid compound, 1 to 5 percent of glycerin, 0.03 to 0.3 percent of sodium hyaluronate, 0.1 to 1 percent of vitamin E, 0.1 to 1 percent of allantoin, 2 to 9 percent of emulsifying system and the balance of purified water. The skin barrier moisturizing and repairing cream disclosed by the invention has the effects of moisturizing for a long time and repairing the skin barrier, has the advantages of being mild and low in irritation, and is suitable for people suffering from atopic dermatitis.

Description

Skin barrier moisturizing and repairing cream and preparation method thereof
Technical Field
The invention relates to a skin barrier moisturizing and repairing cream and a preparation method thereof, in particular to a skin barrier moisturizing and repairing cream suitable for people suffering from atopic dermatitis and a preparation method thereof.
Background
Atopic Dermatitis (AD) is a chronic, recurrent and inflammatory skin disease characterized clinically by severe itching and sleep disorders, often accompanied by Atopic diseases such as asthma, allergic rhinitis, etc., and its pathogenesis includes the breakdown of skin barrier function, external environmental factors, genetic and immunological interactions, etc.
In recent 30 years, the prevalence rate of AD is rising year by year, epidemiological research shows that the prevalence rate of AD in developed countries of Europe and America is about 20-30%, and that the prevalence rate of AD in developed countries of Europe and America is about 10-20%, and the prevalence rate of AD in developing countries is also continuously rising in recent years. In 2004, AD prevalence in preschool children in China was 3.07%, while in 2014 it has reached 12.94%. Of these patients, over 75% are mild to moderate patients with dry skin, a common feature of AD patients, and eczematous lesions as the main clinical manifestations, with approximately 80% of patients presenting dry skin.
The current internationally accepted therapeutic strategy for atopic dermatitis is "stepwise" graded therapy, with incremental therapeutic measures being given depending on the severity of the condition of AD. However, the basic treatment of emollients is an indispensable measure, both for mild AD, which only manifests dry skin, and for refractory or severe AD. A large number of clinical studies at home and abroad prove that the treatment by using the emollient every day can obviously reduce the frequency of AD attack and shorten the time of AD attack, is an important means for preventing AD attack and is a prevention measure with high cost performance and reducing AD burden. The necessity and importance of emollient treatment is well documented in the AD treatment guidelines of europe, the united states, japan and china.
Disclosure of Invention
Based on the above, an object of the present invention is to provide a skin barrier moisturizing and repairing cream suitable for people with atopic dermatitis, which has the effects of moisturizing and repairing skin barrier for a long time, and has the advantages of mildness and low irritation.
Another object of the present invention is to provide a method for preparing the skin barrier moisturizing and repairing cream.
The technical scheme adopted by the invention is as follows:
the skin barrier moisturizing and repairing cream comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000011
Figure RE-GDA0002356182720000021
and the balance purified water.
Further, the oily matrix comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000022
further, the emulsifying system comprises the following components in percentage by weight:
30 to 40 percent of sucrose polystearate,
30 to 40 percent of cetearyl glucoside,
20 to 30 percent of cetearyl alcohol.
Optionally, the emulsifying system comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000023
further, the lipoid compound comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000024
and the balance purified water;
the oil is selected from one or a combination of more than two of caprylic/capric triglyceride, dicaprylyl carbonate and butanediol dicaprylate/dicaprate, the free fatty acid is selected from one or a combination of more than two of lauric acid, palmitic acid and myristic acid, and the phytosterol is selected from one or a combination of more than two of β -sitosterol, stigmasterol and campesterol.
Further, the lipoid compound also comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000031
further, in the lipoid compound, the thickening agent is selected from one or a combination of more than two of sodium polyacrylate, acryloyl dimethyl taurate sodium, carbomer resin, ammonium taurine/behenyl alcohol polyether-25, methacrylate cross-linked polymer, sodium polyacrylate grafted starch and polyvinylpyrrolidone; the preservative is selected from one or more of hexanediol, p-hydroxyacetophenone, phenoxyethanol, hydroxyphenyl esters, pentanediol, caprylyl hydroximic acid and ethylhexyl glycerol; the antioxidant is selected from one or more of dibutyl hydroxy toluene (BHT), Butyl Hydroxy Anisol (BHA) and sodium sulfite; the chelating agent is one or more of ethylenediaminetetraacetic acid (EDTA), disodium ethylenediaminetetraacetate (EDTA-2Na), tetrasodium ethylenediaminetetraacetate (EDTA-4Na), citric acid and sodium citrate.
Optionally, the lipid complex comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000032
and the balance purified water.
Further, the skin barrier moisturizing and repairing cream further comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000041
further, in the skin barrier moisturizing and repairing cream, the thickening agent is selected from one or a combination of more than two of acryloyl dimethyl taurate/vinyl pyrrolidone copolymer, sodium polyacrylate, acryloyl dimethyl taurate, carbomer resin, methacrylate cross-linked polymer, sodium polyacrylate grafted starch and polyvinylpyrrolidone; the preservative is selected from one or more of hexanediol, p-hydroxyacetophenone, phenoxyethanol, hydroxyphenyl esters, pentanediol, caprylyl hydroximic acid and ethylhexyl glycerol; the antioxidant is selected from one or more of dibutyl hydroxy toluene (BHT), Butyl Hydroxy Anisol (BHA) and sodium sulfite; the chelating agent is one or more of ethylenediaminetetraacetic acid (EDTA), disodium ethylenediaminetetraacetate (EDTA-2Na), tetrasodium ethylenediaminetetraacetate (EDTA-4Na), citric acid and sodium citrate.
Optionally, the skin barrier moisturizing and repairing cream comprises the following components in percentage by weight:
Figure RE-GDA0002356182720000042
Figure RE-GDA0002356182720000051
and the balance purified water.
Optionally, the skin barrier moisturizing and repairing cream comprises the following components in percentage by weight:
and the balance purified water.
The preparation method of the skin barrier moisturizing and repairing cream comprises the following steps:
adding a thickening agent and sodium hyaluronate into glycerol, and uniformly stirring to obtain a mixed solution;
taking an oil-based matrix, adding an antioxidant and an emulsification system, stirring, heating and dissolving to obtain an oil phase;
adding allantoin, a preservative and a chelating agent into purified water, stirring and heating uniformly, adding the mixed solution, stirring uniformly, adding the oil phase, emulsifying and homogenizing, adding vitamin E and a lipoid compound, and stirring uniformly to obtain the skin barrier moisturizing and repairing cream.
Further, the preparation method of the oily matrix comprises the following steps: mixing caprylic/capric triglyceride, squalane, shea butter, polydimethylsiloxane and olive oil unsaponifiable matter under heating condition, and stirring to obtain the oily matrix.
Further, the preparation method of the lipoid compound comprises the following steps:
respectively taking oil, ceramide 3, free fatty acid, phytosterol, an antioxidant and a thickening agent, and stirring and mixing uniformly under a heating condition to obtain an oil phase;
adding hydrogenated phosphatidylcholine, glycerol, chelating agent and preservative into purified water respectively, and stirring and mixing uniformly under heating conditions to obtain a water phase;
under the heating condition, slowly adding the oil phase into the water phase, and stirring along the same direction to obtain an emulsified matrix;
and cooling after emulsification is finished, then adding the vitamin E into the emulsified matrix, and uniformly stirring and mixing to obtain the lipoid compound.
The skin barrier moisturizing and repairing cream disclosed by the invention has the effects of quickly reducing the moisture of the skin, increasing the content of the horny layer and repairing the skin barrier, has the advantages of being mild, low in irritation and the like, and is suitable for daily skin moisturizing and repairing treatment of atopic dermatitis crowds.
The formula is designed by selecting physiological lipid such as ceramide 3, free fatty acid, phytosterol and the like according to the proportion of the lipid components of the stratum corneum of the skin, and a bionic lipid compound is constructed to provide a material basis for supplementing the physiological lipid of the stratum corneum and repairing the skin barrier; meanwhile, glycerin, hyaluronic acid, vitamin E and the like are selected to form a moisturizing system, and then a grease moisturizing system is matched, so that the three parts have mutual synergistic effect, the percutaneous moisture loss of the skin can be effectively reduced, the skin cutin barrier can be repaired, and the moisturizing effect is greatly improved; in addition, in order to stabilize the relationship among the three and accord with the mild design concept, the formula adopts a unique emulsifying system, a compact liquid crystal structure can be formed, the same moisturizing effect can be achieved, the using amount of the moisturizing agent can be greatly reduced, and the irritation of the product can be greatly reduced. The complex components such as essence, plant extracts and the like are not added in the formula, so that the irritation and sensitization of the formula can be further reduced.
The lipoid compound in the formula selects the bionic ceramide 3, the free fatty acid and the phytosterol to simulate the proportion of lipid among cells of the stratum corneum of the skin to carry out proportioning, and the ceramide, the free fatty acid and the phytosterol are mutually matched to enable the ceramide, the free fatty acid and the phytosterol molecules to be jointly inlaid among the phosphatidylcholine molecules to form a cross flower liquid crystal structure which is orderly arranged, so that a bionic skin barrier structure is constructed, the skin barrier structure is more attached to the skin of a human body, the water content of the stratum corneum of the skin can be prolonged, and a good skin repairing effect is obtained. In addition, the caprylic/capric triglyceride has good spreadability, compatibility and safety, can make the oily components in the formula well dissolved, can improve the extensibility of the formula, can also be used as a fat-endowing agent, supplements the necessary lipid of the skin, and has the effects of lubricating and softening the skin.
The emulsifying system in the formula selects sucrose polystearate and cetearyl glucoside, or sucrose polystearate and sodium stearoyl lactylate as main emulsifiers, selects cetearyl alcohol and/or glyceryl stearate as auxiliary emulsifiers, and can form a compact liquid crystal structure through reasonable compounding of the two emulsifiers. Wherein, the sucrose polystearate has a structure with a plurality of long chain group tails with hydrophobicity and a relatively small head of hydrophilic group, the cetearyl glucoside and the sodium stearoyl lactylate have a structure with a long chain group tail with hydrophobicity and a relatively large head of hydrophilic group, and the hydrophobic group and the hydrophilic group of the two areThe structure can form proper critical stacking parameters under proper proportion, thereby forming a liquid crystal structure. However, the structural compactness of the two is affected due to the steric hindrance effect between the hydrophilic groups of the two. The structure of the cetearyl alcohol and the glyceryl stearate has a high alcohol fat long chain similar to that of the main emulsifier or a similar lipophilic group and a very small hydrophilic group, so that the steric effect is smaller
Figure RE-GDA0002356182720000071
The emulsifier is added into a liquid crystal system of the main emulsifier, so that a more compact and ordered liquid crystal structure is formed. Meanwhile, the hydrophilic group in the system can form a gel network with water to combine, and the network structure of the gel network enables the mobile phase to be fixed to a certain extent, so that the flocculation effect is effectively prevented, and the stability of the product is improved. The storage capacity of a more compact liquid crystal structure to the water phase is also larger, on one hand, more water phases can be locked, and on the other hand, the slow release effect is realized on the release of water, so that the effects of improving the water content of the stratum corneum (MSC) and reducing the percutaneous water loss (TWEL) are realized.
The oily matrix in the formula adopts caprylic/capric triglyceride, squalane and other components, is grease with good spreadability, and simultaneously controls the dosage of the oily matrix to be 9-25%, so that on one hand, the oily matrix can bring better skin feel, on the other hand, the oily matrix can be matched with a liquid crystal emulsification system to form better physical stability and skin affinity, has moderate sealing effect, is refreshing and not greasy, and can synergistically reduce the loss of skin moisture through skin. In addition, an acryloyl dimethyl ammonium taurate/vinyl pyrrolidone copolymer (acryloyl dimethyl ammonium taurate/VP copolymer) is adopted in the formula, so that the preparation method has the function of stabilizing the suspended emulsion, can improve the stability of an emulsification system, and has extremely low irritation. The moisturizing system is composed of glycerol, sodium hyaluronate and vitamin E, has better water locking and moisturizing and slow-release capabilities under the action of an emulsifying system, and can effectively reduce the percutaneous water loss of skin and improve the water content of stratum corneum; meanwhile, the dosage of the glycerol can be reduced to be within 5 percent, the irritation caused by overhigh dosage of the glycerol is avoided, the dosage of the sodium hyaluronate can be reduced to be within 0.3 percent, and the phenomenon that the rheological property of the product is damaged due to overhigh dosage of the sodium hyaluronate is avoided. Moreover, compared with the traditional preservative system, the preservative system formed by reasonably proportioning the hexanediol and the p-hydroxyacetophenone can also greatly reduce the irritation of the product.
The skin barrier moisturizing repair cream disclosed by the invention has the advantages that a compact liquid crystal structure is formed together through the interaction among the oil moisturizing system, the emulsifying system and the lipoid compound, and a good moisturizing effect can be generated; meanwhile, due to the bionic lamellar liquid crystal structure design of the lipoid compound, physiological lipid can be effectively supplemented for the stratum corneum, the lipid barrier function of the stratum corneum of the skin is repaired, the percutaneous water loss is further reduced, and the water content of the stratum corneum is improved, so that the skin repairing effect is good. During the preparation process, the emulsion formed by the formula can obtain a stable final product through one phase transformation, can show good thixotropy (shear thinning), and can release the oil-phase component and the water-phase component simultaneously when being coated and used.
Drawings
FIG. 1 is a polarization micrograph of a lipid liquid crystal complex prepared according to one example.
FIG. 2 is a graph showing the results of the chick embryo chorioallantoic membrane blood vessel test conducted on the skin barrier moisturizing cream of example III in example VI, FIG. 2A is a graph showing the results of the chick embryo chorioallantoic membrane blood vessel test conducted on the skin barrier moisturizing cream of example IV, FIG. 2B is a graph showing the results of the chick embryo chorioallantoic membrane blood vessel test conducted on the skin barrier moisturizing cream of example IV, and FIG. 2C is a graph showing the results of the chick embryo chorioallantoic membrane blood vessel test conducted on the skin barrier moisturizing cream of example V;
FIG. 3 is a graph showing the results of the percutaneous water loss test in example six.
Fig. 4 is a graph showing the results of the test for increasing the water content of the horny layer according to the sixth example.
Detailed Description
The first embodiment is as follows: preparation of lipid complexes
Weighing the components according to the following formula:
Figure RE-GDA0002356182720000081
the preparation steps are as follows:
adding caprylic acid/capric acid triglyceride into ceramide 3, lauric acid, β -sitosterol and sodium polyacrylate respectively, stirring and heating to 90-100 ℃ for dissolution, keeping the temperature and stirring for 10-20 minutes to mix uniformly, and cooling to 75-85 ℃ to obtain an oil phase;
adding hydrogenated phosphatidylcholine, glycerol, disodium ethylene diamine tetraacetate and p-hydroxyacetophenone into purified water respectively, stirring and heating to 90-100 ℃ for dissolving, keeping the temperature and stirring for 10-20 minutes to uniformly mix, and cooling to 75-85 ℃ to obtain a water phase;
adding the oil phase into the water phase in a trickle shape at 75-85 ℃, and carrying out heat preservation, stirring and homogenizing for 10-20 minutes along the same direction to obtain an emulsified matrix;
and after emulsification is finished, stirring and cooling to below 45 ℃, then adding hexanediol and vitamin E into the emulsifying matrix, stirring uniformly, and continuously cooling to below 38 ℃ to obtain the lipoid liquid crystal compound.
Observing the prepared lipoid liquid crystal compound under a polarizing microscope, as shown in figure 1, molecules such as ceramide 3, lauric acid, β -sitosterol and the like are embedded in a lamellar liquid crystal body of the hydrogenated phosphatidylcholine together to form an orderly-arranged cross-shaped liquid crystal polarizing structure.
The liquid crystal is formed because the liquid crystal emulsifier and the auxiliary emulsifier form an interface film with ordered layers, compactness and viscoelasticity on an oil/water interface, the auxiliary emulsifier and the liquid crystal emulsifier which are properly proportioned are added, the ordered arrangement of the layers can be more favorably formed, and the hydrophilic group and water molecules form a gel network to be combined, so that the formula is more stable.
Example two: preparation of oily base
Weighing the components according to the following formula:
Figure RE-GDA0002356182720000091
the preparation steps are as follows:
and (2) adding caprylic/capric triglyceride into squalane, shea butter, polydimethylsiloxane and olive oil unsaponifiable matter respectively, stirring and heating to 90-100 ℃, and uniformly mixing to obtain the oily matrix.
Example three: preparation of skin barrier moisturizing and repairing cream
Weighing the components according to the following formula:
Figure RE-GDA0002356182720000092
the preparation steps are as follows:
adding acryloyl dimethyl ammonium taurate/VP copolymer, sodium polyacrylate and sodium hyaluronate into glycerol, and uniformly stirring to obtain a mixed solution;
taking an oily matrix, adding dibutyl hydroxy toluene, sucrose polystearate, cetearyl glucoside and cetearyl alcohol, stirring and heating to 90-100 ℃ for dissolving, keeping the temperature and stirring for 10-20 minutes, and then cooling to 75-85 ℃ to obtain an oil phase;
adding allantoin, p-hydroxyacetophenone and disodium ethylene diamine tetraacetate into purified water, stirring and heating to 90-100 ℃ for dissolving, preserving heat and stirring for 10-20 minutes, cooling to 75-85 ℃, adding the mixed solution, stirring for 10-20 minutes, homogenizing for 10-20 minutes, adding the oil phase, stirring and emulsifying for 10-20 minutes, homogenizing for 10-20 minutes, cooling to below 45 ℃, adding hexanediol, vitamin E and lipoid compound, stirring for 10-20 minutes, homogenizing for 10-20 minutes, and cooling to below 40 ℃, thus obtaining the skin barrier moisturizing and repairing cream.
Example four: preparation of skin barrier moisturizing and repairing cream
Weighing the components according to the following formula:
Figure RE-GDA0002356182720000102
Figure RE-GDA0002356182720000111
the preparation steps are as follows:
adding acryloyl dimethyl ammonium taurate/VP copolymer and sodium hyaluronate into glycerol, and uniformly stirring to obtain a mixed solution;
adding dibutyl hydroxy toluene, sucrose polystearate, sodium stearoyl lactylate, cetostearyl alcohol and glycerol stearate into an oily substrate, stirring and heating to 90-100 ℃ for dissolution, preserving heat and stirring for 10-20 minutes, and then cooling to 75-85 ℃ to obtain an oil phase;
adding allantoin, p-hydroxyacetophenone and disodium ethylene diamine tetraacetate into purified water, stirring and heating to 90-100 ℃ for dissolving, preserving heat and stirring for 10-20 minutes, cooling to 75-85 ℃, adding the mixed solution, stirring for 10-20 minutes, homogenizing for 10-20 minutes, adding the oil phase, stirring and emulsifying for 10-20 minutes, homogenizing for 10-20 minutes, cooling to below 45 ℃, adding hexanediol, vitamin E and lipoid compound, stirring for 10-20 minutes, homogenizing for 10-20 minutes, and cooling to below 40 ℃, thus obtaining the skin barrier moisturizing and repairing cream.
Example five: preparation of traditional skin barrier moisturizing and repairing cream
Weighing the components according to the following formula:
Figure RE-GDA0002356182720000112
Figure RE-GDA0002356182720000121
the preparation steps are as follows:
adding sodium hyaluronate into glycerol, and stirring to obtain mixed solution;
taking neopentyl glycol diheptanoate, squalane, behenyl alcohol, C12-20 alkyl glucoside, cetearyl alcohol olive oleate, ceramide 3, cholesterol, octyldodecanol and dibutyl hydroxy toluene, stirring and heating to 90-100 ℃ for dissolving, continuing stirring for 10-20 minutes at a constant temperature, and then cooling to 75-85 ℃ to obtain an oil phase;
adding hydrogenated lecithin, glyceryl polyether-26, betaine, glyceryl polyacrylate, allantoin, p-hydroxyacetophenone and disodium ethylene diamine tetraacetate into purified water, stirring and heating to 90-100 ℃ for dissolution, continuing to keep the temperature and stir for 10-20 minutes, cooling to 75-85 ℃, then respectively adding the mixed solution and acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, stirring for 10-20 minutes, homogenizing for 10-20 minutes, adding an oil phase, stirring and emulsifying for 10-20 minutes, homogenizing for 10-20 minutes, cooling to below 45 ℃, adding vitamin E and hexanediol, continuing to stir and emulsify for 10-20 minutes, homogenizing for 10-20 minutes, and cooling to below 40 ℃ to obtain the traditional skin barrier moisturizing and repairing cream.
Example six: performance testing
1. Irritation test
1) Chick embryo chorioallantoic membrane blood vessel test (CAM test)
The skin barrier moisturizing and repairing creams prepared in the third, fourth and fifth examples were respectively taken and subjected to a chick embryo chorioallantoic membrane blood vessel test to observe the blood vessel changes of the allantoic membrane after being exposed to the skin barrier moisturizing and repairing cream.
The test method comprises the following steps: 40ul of test samples are taken and directly dripped into a test ring on the surface of chorioallantoic membrane in the middle stage of fertilized chicken embryo with the embryo age of 10-14 days, and after the test ring is cultured for 30 minutes in an incubator at 37 ℃, the effect of the CAM blood vessel and the degree of each effect are recorded.
And (3) test results: as shown in fig. 2A, 2B and 2C, the skin barrier moisturizing and conditioning creams of examples three and four exhibited no irritation in the CAM test, were extremely mild in nature, and did not cause bleeding damage to the allantoic membrane vessels of chick embryo chorionic allantoic membrane; the skin barrier moisturizer of example five showed mild irritation in the CAM test, causing mild bleeding damage to the chorioallantoic vessels of chicken embryo hair.
And (4) judging the standard:
2) multiple skin irritation test
According to the method of "skin irritation/corrosion test" in the cosmetic safety specification 2015, the skin barrier moisturizing and repairing creams prepared in the third and fourth examples were respectively used, and rabbits were used as test animals to perform a skin irritation test.
The test method comprises the following steps: the test samples were applied to the skin of test animals (rabbits), wherein the sample groups were coated with the skin barrier moisturizing creams of example three and example four, respectively, and the blank group was coated with purified water, and the skin irritation degree of the test animals was observed and scored at regular time intervals.
And (4) judging the standard:
Figure RE-GDA0002356182720000132
and (3) test results:
the test results show that the skin barrier moisturizing and repairing creams of the third embodiment and the fourth embodiment are non-irritant and have extremely mild properties.
3) Patch test on human skin
According to the method of the skin patch test for human body in the 2015 edition of the technical Specification for cosmetic safety, the skin barrier moisturizing and repairing creams prepared in the third and fourth examples are respectively taken to carry out the skin patch test for human body.
The test method comprises the following steps: selecting 30 subjects with an area of 50mm or less2And a spot tester with the depth not more than 1mm, wherein 0.02 g-0.025 g of test sample is smeared in the spot tester and then is pasted on the back of a subject. Wherein, the sample groups were coated with the skin barrier moisturizing cream of example three and example four, respectively, and the blank group was coated with purified water. After 24 hours, the plaque tester was removed, and the skin reaction of the subject was observed at 0.5 hour, 24 hours, and 48 hours after the removal, respectively, and the results of the skin reaction scale were recorded.
And (4) judging the standard: skin reaction grade standard of skin closed patch test
Figure RE-GDA0002356182720000151
And (3) test results:
Figure RE-GDA0002356182720000152
the test results show that the skin barrier moisturizing and repairing creams of the third embodiment and the fourth embodiment have no allergic reaction in the human skin patch test.
2. Percutaneous Water loss (TWEL) test
The skin barrier moisturizing and repairing creams prepared in the third, fourth and fifth examples were respectively used for a percutaneous water loss test with a human body as a parameter object (20 subjects per group).
The test method comprises the following steps: after the test site (inner side of front arm) was washed by the subject, the test site was marked with a test area (test area about 4 cm)2) And one arm is used as blank control, and the corresponding area of the other arm is smeared with the test sample. Under the condition of a constant temperature and humidity environment, after a subject enters a testing room and sits statically for 30 minutes, a percutaneous water loss measuring instrument is adopted to carry out initial reading on a testing area and a blank control area respectively; then, weighing a proper amount of test sample, uniformly coating the test sample in the test area, not processing the blank control area, reading the test area at regular intervals, and recording data.
And (3) test results:
Figure RE-GDA0002356182720000161
test results show that after the skin barrier moisturizing and repairing cream provided by the third embodiment and the fourth embodiment of the invention is used, the percutaneous water loss can be rapidly reduced and can be maintained for a long time, and the skin barrier moisturizing and repairing cream is obviously superior to the traditional skin barrier moisturizing and repairing cream provided by the fifth embodiment.
3. Stratum corneum water content (MSC) lifting test
The skin barrier moisturizing and repairing creams prepared in the third, fourth and fifth examples were respectively used for stratum corneum water content increase test with human body as a parameter object (20 subjects per group).
The test method comprises the following steps: after the subject washes the test site (e.g., arm, forehead, etc.), the test site is circled to make a test area mark (test area about 4 cm)2) And selecting the area with the same size above the blank area as the blank control area. Under the condition of a constant temperature and humidity environment, after a subject enters a testing room and sits for 30 minutes, a stratum corneum water content tester is adopted to carry out initial reading on a testing area and a blank control area respectively; then, weighing a proper amount of test sample, uniformly coating the test sample in the test area, not processing the blank control area, reading the test area at regular intervals, and recording data.
And (3) test results:
Figure RE-GDA0002356182720000162
Figure RE-GDA0002356182720000171
test results show that the skin barrier moisturizing and repairing creams of the third embodiment and the fourth embodiment improve the moisture content of the stratum corneum by over 80 percent; the skin barrier moisturizing treatment cream of example five increased the moisture content of the stratum corneum by only about 60%.
4. Stability test
1) Accelerated test at 40 ℃
The test method comprises the following steps: the skin barrier moisturizing repair creams prepared in the third and fourth examples were placed in a 40 ℃ incubator, and examined for pH, uniformity, discoloration, and centrifugation within 3 months, and compared with the samples obtained at room temperature for 0 day.
And (3) test results: the skin barrier moisturizing and repairing creams prepared in the third and fourth examples have good uniformity, no delamination after centrifugation and no obvious difference in pH value and color change compared with the samples obtained after 0 day at normal temperature under the condition of 3 months at 40 ℃.
2) Low temperature test at-15 deg.C
The test method comprises the following steps: the skin barrier moisturizing and repairing creams prepared in the third and fourth examples were placed in an incubator at-15 ℃ to examine the pH value, uniformity, discoloration and centrifugation within 1 month, and compared with the samples obtained at room temperature for 0 day.
And (3) test results: the skin barrier moisturizing and repairing creams prepared in the third and fourth examples have good uniformity, no delamination after centrifugation and no obvious difference in pH value and color change compared with the samples obtained after 0 day at normal temperature under the condition of 1 month at-15 ℃.
3) Cold and hot cycle test
The test method comprises the following steps: the skin barrier moisturizing repair creams prepared in the third and fourth examples were placed in an incubator at 60 ℃ for 24 hours and then in an incubator at-15 ℃ for 24 hours, and the above steps were repeated 9 times to examine the properties, pH and consistency of the product after returning to room temperature, and compared with a sample at room temperature for 0 day.
And (3) test results: after 9 times of cold and hot cycles, the skin barrier moisturizing and repairing creams prepared in the third and fourth examples are uniform, fine and smooth in cream body, and have no obvious difference in pH value and consistency compared with the samples obtained after 0 day at normal temperature.
The stability test result shows that the skin barrier moisturizing repair cream prepared in the third example and the fourth example has good stability.
5. Test for Corrosion resistance
The skin barrier moisturizing skin creams prepared in example three and example four were respectively tested for antisepsis according to the microbial antisepsis efficacy test method of United states pharmacopoeia USP32<51 >. The test strains include: bacteria (Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Burkholderia cepacia) and molds (Candida albicans, Aspergillus niger).
And (4) testing standard:
Figure RE-GDA0002356182720000181
and (3) testing results:
Figure RE-GDA0002356182720000182
the test results show that the bacterial mold of the antiseptic system of the skin barrier moisturizing and repairing creams of the third embodiment and the fourth embodiment does not increase after 14 days, and the reduction log value is larger than 2.
6. Risk substance testing
The skin barrier moisturizing repair creams prepared in example three and example four were subjected to the risk substance content test according to the risk substance test method of the cosmetic safety technical code 2015 edition.
And (3) testing results:
Figure RE-GDA0002356182720000183
Figure RE-GDA0002356182720000191
the test results show that the skin barrier moisturizing and repairing creams of the third embodiment and the fourth embodiment have the content of risk substances far smaller than the limit of national standards.
The comprehensive test results show that the skin barrier moisturizing and repairing cream prepared by the invention can effectively reduce the percutaneous water loss and improve the water content of the stratum corneum, has the effect of repairing the skin barrier, and has the advantages of mild property and low irritation.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.

Claims (10)

1. The skin barrier moisturizing and repairing cream is characterized by comprising the following components in percentage by weight:
Figure FDA0002312826670000011
and the balance purified water.
2. The skin barrier moisturizing and repairing cream as claimed in claim 1, wherein the oily base comprises the following components by weight percent:
3. the skin barrier moisturizing and repairing cream as claimed in claim 1, wherein the emulsifying system comprises the following components in percentage by weight:
30 to 40 percent of sucrose polystearate,
30 to 40 percent of cetearyl glucoside,
20 to 30 percent of cetearyl alcohol;
or the emulsifying system comprises the following components in percentage by weight:
Figure FDA0002312826670000013
4. the skin barrier moisturizing and repairing cream as claimed in claim 1, wherein the lipid compound comprises the following components by weight percent:
Figure FDA0002312826670000014
Figure FDA0002312826670000021
and the balance purified water;
the oil is selected from one or a combination of more than two of caprylic/capric triglyceride, dicaprylyl carbonate and butanediol dicaprylate/dicaprate, the free fatty acid is selected from one or a combination of more than two of lauric acid, palmitic acid and myristic acid, and the phytosterol is selected from one or a combination of more than two of β -sitosterol, stigmasterol and campesterol.
5. The skin barrier moisturizing and repairing cream as claimed in claim 4, wherein the lipid compound further comprises the following components by weight percent:
Figure FDA0002312826670000022
wherein the thickening agent is selected from one or the combination of more than two of sodium polyacrylate, acryloyl dimethyl taurate, carbomer resin, ammonium taurine/behenyl alcohol polyether-25, methacrylate cross-linked polymer, sodium polyacrylate grafted starch and polyvinylpyrrolidone; the preservative is selected from one or more of hexanediol, p-hydroxyacetophenone, phenoxyethanol, hydroxyphenyl esters, pentanediol, caprylyl hydroximic acid and ethylhexyl glycerol; the antioxidant is selected from one or a combination of more than two of dibutyl hydroxy toluene, butyl hydroxy anisol and sodium sulfite; the chelating agent is one or more of ethylenediamine tetraacetic acid, disodium ethylenediamine tetraacetic acid, tetrasodium ethylenediamine tetraacetic acid, citric acid and sodium citrate.
6. The skin barrier moisturizing and repairing cream as claimed in claim 5, wherein the lipid compound comprises the following components by weight percent:
Figure FDA0002312826670000023
Figure FDA0002312826670000031
and the balance purified water.
7. The skin barrier moisturizing and repairing cream as claimed in one of claims 1 to 6, wherein the skin barrier moisturizing and repairing cream further comprises the following components by weight percent:
Figure FDA0002312826670000032
wherein the thickening agent is selected from one or the combination of more than two of acryloyl dimethyl ammonium taurate/vinyl pyrrolidone copolymer, sodium polyacrylate, acryloyl dimethyl sodium taurate, carbomer resin, methacrylate cross-linked polymer, sodium polyacrylate grafted starch and polyvinylpyrrolidone; the preservative is selected from one or more of hexanediol, p-hydroxyacetophenone, phenoxyethanol, hydroxyphenyl esters, pentanediol, caprylyl hydroximic acid and ethylhexyl glycerol; the antioxidant is selected from one or a combination of more than two of dibutyl hydroxy toluene, butyl hydroxy anisol and sodium sulfite; the chelating agent is one or more of ethylenediamine tetraacetic acid, disodium ethylenediamine tetraacetic acid, tetrasodium ethylenediamine tetraacetic acid, citric acid and sodium citrate.
8. The skin barrier moisturizing and repairing cream as claimed in claim 7, wherein the skin barrier moisturizing and repairing cream comprises the following components by weight percent:
Figure FDA0002312826670000033
Figure FDA0002312826670000041
and the balance purified water.
9. The skin barrier moisturizing and repairing cream as claimed in claim 7, wherein the skin barrier moisturizing and repairing cream comprises the following components by weight percent:
Figure FDA0002312826670000042
Figure FDA0002312826670000051
and the balance purified water.
10. A preparation method of a skin barrier moisturizing and repairing cream comprises the following steps:
adding a thickening agent and sodium hyaluronate into glycerol, and uniformly stirring to obtain a mixed solution;
taking an oil-based matrix, adding an antioxidant and an emulsification system, stirring, heating and dissolving to obtain an oil phase;
adding allantoin, a preservative and a chelating agent into purified water, stirring and heating uniformly, adding the mixed solution, stirring uniformly, adding the oil phase, emulsifying and homogenizing, adding vitamin E and a lipoid compound, and stirring uniformly to obtain the skin barrier moisturizing and repairing cream.
CN201911265886.1A 2019-12-11 2019-12-11 Skin barrier moisturizing and repairing cream and preparation method thereof Active CN110812273B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911265886.1A CN110812273B (en) 2019-12-11 2019-12-11 Skin barrier moisturizing and repairing cream and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911265886.1A CN110812273B (en) 2019-12-11 2019-12-11 Skin barrier moisturizing and repairing cream and preparation method thereof

Publications (2)

Publication Number Publication Date
CN110812273A true CN110812273A (en) 2020-02-21
CN110812273B CN110812273B (en) 2022-11-22

Family

ID=69544675

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911265886.1A Active CN110812273B (en) 2019-12-11 2019-12-11 Skin barrier moisturizing and repairing cream and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110812273B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111249209A (en) * 2020-03-30 2020-06-09 广东芭薇生物科技股份有限公司 Moisturizing repair cream and preparation method thereof
CN111529464A (en) * 2020-05-20 2020-08-14 广东创美抗衰老研究有限公司 Moisturizing cream suitable for diabetic patients
CN111557856A (en) * 2020-05-22 2020-08-21 广东创美抗衰老研究有限公司 Preparation method of lithospermum repairing cream
CN111773111A (en) * 2020-05-20 2020-10-16 广东创美抗衰老研究有限公司 Hand and foot repairing cream suitable for diabetic patients
CN113398003A (en) * 2021-07-01 2021-09-17 广州市科能化妆品科研有限公司 Skin repairing special cream and preparation method thereof
CN115363999A (en) * 2022-08-23 2022-11-22 时垠(上海)生物科技有限公司 Water-dispersible composition for repairing and maintaining skin barrier and application thereof
KR102627686B1 (en) * 2023-08-17 2024-01-24 코스맥스 주식회사 Liquid crystal cream cosmetic composition that looks like snow particles with a gloss improving effect and manufacturing method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL159591B1 (en) * 1989-05-31 1992-12-31 Cream for protection of skin against aqueous solutions of electrolytes
CN108619018A (en) * 2018-05-14 2018-10-09 杨森 A kind of skin barrier repair cream and preparation method thereof
CN109394580A (en) * 2018-12-04 2019-03-01 珠海依赛思生物科技有限公司 A kind of ceramide is releived moisturizing maintenance frost and preparation method thereof
CN109481338A (en) * 2019-01-04 2019-03-19 上海彤颜实业有限公司 Moisturizing maintenance composition and preparation method comprising ceramide and phytosterol
CN109865160A (en) * 2019-04-04 2019-06-11 广东华润顺峰药业有限公司 A kind of Liquid crystal compound and preparation method thereof
CN109875910A (en) * 2019-04-19 2019-06-14 武汉百思凯瑞生物科技有限公司 A kind of complex polypeptide nano vesicle and its preparation method and application with skin repair function
CN110478272A (en) * 2019-09-17 2019-11-22 广东丸美生物技术股份有限公司 Skin matrix and its preparation method and application

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL159591B1 (en) * 1989-05-31 1992-12-31 Cream for protection of skin against aqueous solutions of electrolytes
CN108619018A (en) * 2018-05-14 2018-10-09 杨森 A kind of skin barrier repair cream and preparation method thereof
CN109394580A (en) * 2018-12-04 2019-03-01 珠海依赛思生物科技有限公司 A kind of ceramide is releived moisturizing maintenance frost and preparation method thereof
CN109481338A (en) * 2019-01-04 2019-03-19 上海彤颜实业有限公司 Moisturizing maintenance composition and preparation method comprising ceramide and phytosterol
CN109865160A (en) * 2019-04-04 2019-06-11 广东华润顺峰药业有限公司 A kind of Liquid crystal compound and preparation method thereof
CN109875910A (en) * 2019-04-19 2019-06-14 武汉百思凯瑞生物科技有限公司 A kind of complex polypeptide nano vesicle and its preparation method and application with skin repair function
CN110478272A (en) * 2019-09-17 2019-11-22 广东丸美生物技术股份有限公司 Skin matrix and its preparation method and application

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
广东华润顺峰药业有限公司: ""顺峰宝宝皮肤屏障保湿修护霜"", 《国产非特殊用途化妆品备案服务平台》, 18 January 2019 (2019-01-18), pages 1 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111249209A (en) * 2020-03-30 2020-06-09 广东芭薇生物科技股份有限公司 Moisturizing repair cream and preparation method thereof
CN111249209B (en) * 2020-03-30 2022-03-11 广东芭薇生物科技股份有限公司 Moisturizing repair cream and preparation method thereof
CN111529464A (en) * 2020-05-20 2020-08-14 广东创美抗衰老研究有限公司 Moisturizing cream suitable for diabetic patients
CN111773111A (en) * 2020-05-20 2020-10-16 广东创美抗衰老研究有限公司 Hand and foot repairing cream suitable for diabetic patients
CN111557856A (en) * 2020-05-22 2020-08-21 广东创美抗衰老研究有限公司 Preparation method of lithospermum repairing cream
CN113398003A (en) * 2021-07-01 2021-09-17 广州市科能化妆品科研有限公司 Skin repairing special cream and preparation method thereof
CN115363999A (en) * 2022-08-23 2022-11-22 时垠(上海)生物科技有限公司 Water-dispersible composition for repairing and maintaining skin barrier and application thereof
KR102627686B1 (en) * 2023-08-17 2024-01-24 코스맥스 주식회사 Liquid crystal cream cosmetic composition that looks like snow particles with a gloss improving effect and manufacturing method thereof

Also Published As

Publication number Publication date
CN110812273B (en) 2022-11-22

Similar Documents

Publication Publication Date Title
CN110812273B (en) Skin barrier moisturizing and repairing cream and preparation method thereof
CN109865160B (en) Lipid-like liquid crystal compound and preparation method thereof
CN107397714B (en) Have effects that anti-blue light contamination and desalinates essence cream and its preparation and application of microgroove
TWI238724B (en) The pharmaceutical and cosmetic composition for increasing skin lipid with the component of vegetable oil
CN107468621B (en) Allergy-relieving skin-care emulsion and preparation method thereof
CN114177109B (en) Composite ceramide nano composition and preparation method and application thereof
CN109091411A (en) A kind of infant&#39;s lotion and preparation method thereof
CN111329885B (en) Pharmaceutical composition and cosmetic composition for improving or preventing symptoms of high altitude red, preparation method of pharmaceutical composition and cosmetic
CN109431873B (en) Composition for repairing and relieving skin inflammation
TW201513853A (en) Formulations for epidermal repair and treatment of dermatological diseases and disorders
WO2023109289A1 (en) Composition containing plant fruit oil and plant seed oil, and use thereof
US20220339090A1 (en) Retinal-containing multilamellar vesicle and cosmetic composition comprising same
CN109806177A (en) A kind of high-efficiency moisturizing composition
CN114224787A (en) Composition containing vegetable seed oil and fat and application thereof
JP4398641B2 (en) Hypoallergenic and non-irritating skin care preparations
CN114224786A (en) Composition comprising ceramide and uses thereof
WO1998034589A1 (en) Skin care product
CN113559049A (en) Sustained-release moisturizing cream and preparation method thereof
Kassem et al. Topical caffeine-loaded nanostructured lipid carriers for enhanced treatment of cellulite: A 32 full factorial design optimization and in vivo evaluation in rats
JP5179096B2 (en) Cornified envelope formation / maturation promoter
CN114796059A (en) Moisturizing and repairing composition, skin care product and preparation method of skin care product
US20110165203A1 (en) A topical composition comprising the isolated non-polar lipid fraction of lanolin4
KR102650191B1 (en) Emulsion comprising green ceramide and hydresia oleosome, and cosmetic composition for skin moisturizing, skin barrier reinforcement, skin soothing or sensitive skin improvement comprising the same
CN111973471A (en) Cosmetic composition
CN115670997B (en) Emulsifying system for skin, method for preparing same, and cosmetic containing same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant